Key facts
- Sibel Health’s last known valuation is $215.0M (Sep 2025).
- It has raised $105.2M across 1 recorded rounds; the latest was Early Stage VC ($25.0M) in Jun 2022.
- Notable investors include MedTech Innovator, National Institutes of Health, Samsung NEXT Ventures, Gates Foundation, Dräger — 13 tracked in total.
- Sibel Health has filed 1 Form D with the SEC, most recently Jul 2022 ($25.0M sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Sibel Health
Funding rounds
1 roundsAbout Sibel Health
Developer of clinical-grade health monitoring devices designed to measure heart rate, respiratory rate, skin temperature, body position and activities of patients and pregnant mothers. The company offers advanced motion sensor-based chest monitoring and limb sensor devices and provides a comprehensive physiological monitoring platform with advanced analytics for both clinical care and research applications, enabling medical professionals with wireless vital sign monitoring through biocompatible medical-grade silicone devices.
- Sector
- Healthcare
- HQ
- Chicago, IL, United States
- Founded
- 2017
- Employees
- 104
- Website
- sibelhealth.com/
- Ownership
- Privately Held (backing)
Sibel Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sibel Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sibel Health in its N-PORT filings yet. We sweep new filings monthly.